•  •  Dark Mode

Your Interests & Preferences

I am a...

law firm lawyer
in-house company lawyer
litigation lawyer
law student
aspiring student
other

Website Look & Feel

 •  •  Dark Mode
Blog Layout

Save preferences
Subscribe for perks & to support LI

2018’s 50 busiest Supreme Court AOR law firms • Khaitan leads in Big 7 with 213 filings • JSA, SAM also 100+

113 people have already read this article, which will unlock for non-subscribers like you in . So what are you waiting for? Subscribe now!

Veritas, Khaitan on $100m Recipharm infusion in Nitin Lifesciences

Veritas Legal advised Recipharm AB, a Swedish pharmaceutical company on investing $103m (Rs 671.2 crore) in Nitin Lifesciences, an Indian pharma company which was advised by Khaitan & Co.

Veritas partner Partner Nandish Vyas and Associates Natasha Sethna and Tejasvi Saxena acted for Recipharm.

Khaitan Mumbai partner Kalpana Unadkat, senior associate Shweta Dwivedi and associate Bidya Mohanty acted for Nitin Lifesciences.

Recipharm, will buy 74 per cent in Nitin Lifesciences, reported Livemint

No comments yet: share your views

Latest comments